This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. We have grown crystals of a new drug target protein, prostase, that diffract to 3.5 Angstrom on our rotating anode source and we are hoping that they will diffract to high enough resolution at a syncrotron beamline to solve the structure. We plan to use this Rapid Access time to test diffraction and improve cryo-protection protocols. Prostase is a recently identified target for the diagnosis and/or treatment of prostate cancer.
Showing the most recent 10 out of 604 publications